Clinical Trial: Safety, Pharmacokinetic (PK) Profile and Efficacy of Inpegsomatropin Injection in Adults With Growth Hormone Deficiency

U.S., April 28 -- ClinicalTrials.gov registry received information related to the study (NCT07551804) titled 'Safety, Pharmacokinetic (PK) Profile and Efficacy of Inpegsomatropin Injection in Adults With Growth Hormone Deficiency' on April 15.

Brief Summary: This is a multiple-dose, dose-escalation, randomized, double-blind, placebo-controlled phase Ⅱa clinical trial. A total of 36 adult participants with growth hormone deficiency will be enrolled sequentially in ascending dose cohorts, and within each dose cohort, participants will be randomized in a 3:1 ratio.

Study Start Date: May 31

Study Type: INTERVENTIONAL

Condition: Adult Growth Hormone Deficiency

Intervention: DRUG: Inpegsomatropin Injection

Inpegsomatropin Injection,...